15 Best Oncolytic Virus Startups to Watch in 2025

The Definitive Seedtable Ranking of Oncolytic Virus Startups

We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.

There are 15 start-ups with an aggregate funding of $632.8m. The average funding per company in this subset is $42.2m.

Last update to the database: Feb 18, 2025. See changelog.

See all results for this search

Track over 71,000 companies

Discover
Fast-growing Global startups

Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.

Pricing + Sign up

2

Funding Rounds

$22.0m

Money raised

TILT Biotherapeutics is a biotechnology company developing t-cell therapies using onolytic viruses for treating cancer.

5

Funding Rounds

$65.8m

Money raised

Theolytics Ltd is an oncolytic Adenovirus Therapies founded in 2017.

1

Funding Rounds

$1.0m

Money raised

Jivana Biotechnology develops preclinical stage drugs for application in cancer treatment.

4

Funding Rounds

$69.0m

Money raised

Abalos Therapeutics is a viral Immuno-Oncology Treatment founded in 2005.

2

Funding Rounds

$121.4m

Money raised

Turnstone Biologics is an oncolytic viral immunotherapy founded in 2015.

4

Funding Rounds

$46.7m

Money raised

Immunooncology platform developing tumor antigen-coated oncolytic viruses as therapeutic vaccines.

Location:

Key people:

1

Funding Rounds

$4.7m

Money raised

CG Oncology is an Irvine, California-based company.

1

Funding Rounds

$885.6k

Money raised

A biotechnology company that develops virus-driven immunotherapies for cancer

2

Funding Rounds

$2.0m

Money raised

Sagetis Biotech is a company that is committed to developing an innovative polymeric technology

2

Funding Rounds

$67.3m

Money raised

Vyriad is a Rochester, Minnesota-based company founded in 2015.

2

Funding Rounds

$75.0m

Money raised

Oncolytic Immunotherapy

1

Funding Rounds

$77.0m

Money raised

IconOVir Bio is an oncolytic Virus Therapy.

1

Funding Rounds

$22.0m

Money raised

Cold Genesys is a privately-held, immunotherapy based biopharmaceutical company

1

Funding Rounds

$55.0m

Money raised

NousCom is a cancer Immunotherapies founded in 2015.

1

Funding Rounds

$3.0m

Money raised

Cancer Immunotherapy

Sign up to access our full database

Enter your email and get access to 71,000 + technology companies you can partner with.

Join 29000+ founders, operators, and investors.